ArticleFrontiers in endocrinology2026
The mediating role of testosterone in the relationship between body fat percentage and diabetes mellitus risk.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obesity is one of the major risk factors for diabetes mellitus (DM), and testosterone plays a pivotal role in metabolic regulation. However, it remains unclear whether testosterone exerts a mediating effect in the association between body fat percentage (BFP) and DM. Methods: Clinical data (N = 4433) from Shengjing Hospital were used to assess the BFP-DM association, modeled via restricted cubic spline (RCS). Cross-sectional data from the National Health and Nutrition Examination Survey (NHANES, N = 4772) were then used for observational validation of the mediating pathway and analysis of gender differences. Cross-sectional NHANES data validated the mediating pathway and examined gender differences. Causal relationships of BFP with a mediator (testosterone) and outcomes (blood glucose, T1DM, T2DM) were evaluated using Mendelian randomization (MR), with inverse variance weighting (IVW) as the primary analysis. Sensitivity analyses (MR-Egger, weighted median, MR-PRESSO) assessed pleiotropy and heterogeneity. Results: Clinical data showed BFP was associated with DM (OR = 2.684, 95% CI 1.981-3.638). NHANES results indicated testosterone may mediate the BFP-DM association, accounting for 6.24% (95% CI 2.84%-10.68%) of the total effect, with significant gender differences: significant in males (14.92%, 95% CI 6.49%-25.29%) but not in females. MR analysis validated these associations: higher BFP may elevate blood glucose (OR = 1.147, 95% CI 1.097-1.200) and T2DM risk (OR = 2.456, 95% CI 2.120-2.845), while reducing testosterone (OR = 0.614, 95% CI 0.521-0.724). Mediation analysis showed testosterone partially mediated BFP's effect on blood glucose (8.63%, 95% CI 2.19%-15.10%) and T2DM risk (3.80%, 95% CI 0.62%-6.98%), but no significant mediation was found for BFP and T1DM. Conclusion: This study speculates that testosterone partially mediates the effect of BFP on DM risk, especially in males. However, further prospective studies are needed to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.